Nutrisystem, Inc. (NTRI) Reaches $52.28 Formed H&S; Last Week Supernus Pharmaceuticals, Inc. (SUPN) Coverage

December 7, 2017 - By Vivian Currie

Nutrisystem, Inc. (NTRI) formed H&S with $50.71 target or 3.00% below today’s $52.28 share price. Nutrisystem, Inc. (NTRI) has $1.56B valuation. The stock decreased 0.14% or $0.075 during the last trading session, reaching $52.275. About 7,461 shares traded. Nutrisystem, Inc. (NASDAQ:NTRI) has risen 92.84% since December 7, 2016 and is uptrending. It has outperformed by 76.14% the S&P500.

Among 10 analysts covering Supernus Pharmaceuticals (NASDAQ:SUPN), 7 have Buy rating, 0 Sell and 3 Hold. Therefore 70% are positive. Supernus Pharmaceuticals had 34 analyst reports since August 26, 2015 according to SRatingsIntel. PiperJaffray upgraded Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) on Thursday, June 1 to “Overweight” rating. The rating was downgraded by Zacks to “Hold” on Wednesday, August 26. The company was upgraded on Wednesday, November 8 by Stifel Nicolaus. Piper Jaffray maintained it with “Hold” rating and $4500 target in Thursday, August 3 report. The rating was maintained by Cowen & Co on Tuesday, September 19 with “Buy”. The firm earned “Buy” rating on Monday, December 4 by Janney Capital. The stock has “Market Perform” rating by Northland Capital on Monday, July 18. Piper Jaffray downgraded the shares of SUPN in report on Monday, July 18 to “Neutral” rating. The rating was maintained by Jefferies on Tuesday, September 5 with “Buy”. Stifel Nicolaus maintained the stock with “Buy” rating in Monday, July 17 report. See Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) latest ratings:

04/12/2017 Broker: Janney Capital Old Rating: Neutral New Rating: Buy Old Target: $47 Upgrade
20/11/2017 Broker: FBR Capital Rating: Buy New Target: $50.0 Maintain
08/11/2017 Broker: FBR Capital Rating: Buy New Target: $50.0
08/11/2017 Broker: B. Riley & Co Rating: Buy Old Target: $53 New Target: $50 Maintain
08/11/2017 Broker: Stifel Nicolaus Old Rating: Hold New Rating: Buy Upgrade
06/11/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $50.0 Maintain
27/10/2017 Broker: Piper Jaffray Rating: Hold New Target: $41.0 Maintain
23/10/2017 Broker: Cowen & Co Rating: Buy New Target: $50.0 Maintain
20/10/2017 Broker: Stifel Nicolaus Rating: Hold New Target: $47.0 Maintain
18/10/2017 Broker: FBR Capital Rating: Buy New Target: $53.0 Initiate

Supernus Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system diseases in the United States. The company has market cap of $1.87 billion. It offers Oxtellar XR, an extended-release oxcarbazepine for use in the treatment of epilepsy; and Trokendi XR, an extended-release topiramate, which is used for the treatment of epilepsy. It has a 33.21 P/E ratio. The companyÂ’s product candidates comprise SPN-810, a molindone hydrochloride that is in Phase III clinical trial for the treatment of impulsive aggression in patients with attention deficit hyperactivity disorder ; and SPN-812, a viloxazine hydrochloride, which has completed Phase IIb trial that is used for the treatment of ADHD.

Investors sentiment increased to 1.32 in 2017 Q2. Its up 0.13, from 1.19 in 2017Q1. It improved, as 22 investors sold Supernus Pharmaceuticals, Inc. shares while 82 reduced holdings. 55 funds opened positions while 82 raised stakes. 47.04 million shares or 4.82% more from 44.87 million shares in 2017Q1 were reported. 422,168 are held by Mutual Of America Cap Mgmt Lc. Employees Retirement Sys Of Texas has invested 0.02% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Ingalls Snyder Ltd Liability Corp, New York-based fund reported 175,635 shares. Ny State Common Retirement Fund has 0.02% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Paradigm Asset Management Com Ltd stated it has 15,500 shares. Strs Ohio invested in 0.02% or 121,800 shares. Virginia Retirement Et Al holds 68,200 shares or 0.04% of its portfolio. Moreover, Aperio Limited has 0% invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). First Personal stated it has 353 shares or 0% of all its holdings. Fortaleza Asset Mgmt owns 5,125 shares. Rice Hall James & Associates Ltd Liability Com stated it has 2.55% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). 248,488 were accumulated by Wellington Gp Incorporated Llp. Petrus Tru Lta accumulated 6,470 shares. Creative Planning stated it has 0% in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN). Reilly Fincl Advsrs Limited Liability invested in 0.01% or 2,000 shares.

The stock increased 0.14% or $0.05 during the last trading session, reaching $36.5. About 16,385 shares traded. Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) has risen 91.80% since December 7, 2016 and is uptrending. It has outperformed by 75.10% the S&P500.

Investors sentiment increased to 1.52 in Q2 2017. Its up 0.12, from 1.4 in 2017Q1. It improved, as 21 investors sold Nutrisystem, Inc. shares while 64 reduced holdings. 54 funds opened positions while 75 raised stakes. 31.91 million shares or 17.38% more from 27.18 million shares in 2017Q1 were reported. Rhumbline Advisers reported 0.01% in Nutrisystem, Inc. (NASDAQ:NTRI). Huntington Bank accumulated 1,867 shares. Mckinley Cap Ltd Limited Liability Company Delaware owns 0% invested in Nutrisystem, Inc. (NASDAQ:NTRI) for 780 shares. Brown Advisory reported 6,806 shares. Moreover, State Of Tennessee Treasury Department has 0.01% invested in Nutrisystem, Inc. (NASDAQ:NTRI) for 27,964 shares. The California-based Rice Hall James Assoc has invested 0.11% in Nutrisystem, Inc. (NASDAQ:NTRI). Moreover, Lpl Fincl Ltd Liability Company has 0% invested in Nutrisystem, Inc. (NASDAQ:NTRI). Great West Life Assurance Co Can holds 0.01% of its portfolio in Nutrisystem, Inc. (NASDAQ:NTRI) for 44,055 shares. Thrivent Financial For Lutherans reported 0.16% of its portfolio in Nutrisystem, Inc. (NASDAQ:NTRI). Acadian Asset Mngmt Lc invested in 0.23% or 989,763 shares. Ameritas Inv Prns reported 0.01% in Nutrisystem, Inc. (NASDAQ:NTRI). State Board Of Administration Of Florida Retirement System owns 18,900 shares or 0% of their US portfolio. Timpani Capital Ltd Liability invested in 0.49% or 25,481 shares. Northern Tru invested in 0.01% or 425,972 shares. Wells Fargo & Mn owns 352,836 shares or 0.01% of their US portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: